|
CN110563628A
|
|
Crystallization method for preparing high-purity and monodisperse I crystal form atorvastatin calcium by double kettles
|
|
CN111848528A
|
|
Compound for preventing and/or treating cancer and preparation method and application thereof
|
|
CN109621643A
|
|
The removing method of peculiar smell in Mizolastine production process
|
|
CN109734683A
|
|
The method that Trimetazidine production waste is converted to utility
|
|
CN108675972A
|
|
A kind of preparation method of Amiodarone Hydrochloride intermediate 2- butyl benzofurans
|
|
CN107941959A
|
|
A kind of liquid-phase chromatography method for separating Ezetimibe and its optical isomer
|
|
CN107875129A
|
|
A kind of Ezetimibe atorvastatin preparation method
|
|
CN109748873A
|
|
The purposes of compound and its treating cancer
|
|
CN106699802A
|
|
Purification method for intermediate of atorvastatin
|
|
CN106389370A
|
|
Stable atorvastatin calcium tablet
|
|
CN106478591A
|
|
A kind of method for splitting of atorvastatin condensation substance intermediate
|
|
CN105012258A
|
|
Preparation method of atorvastatin calcium and amlodipine tablets
|
|
CN105012257A
|
|
Method for preparing amlodipine atorvastatin calcium tablets
|
|
CN104945300A
|
|
Purification method for I-type atorvastatin calcium
|
|
CN104931599A
|
|
Determining method of atorvastatin calcium related substance
|
|
CN104031020A
|
|
Preparation method of o-hydroxyl Olopatadine
|
|
CN103664653A
|
|
Method for preparing 2-[(N-benzyl-N-phenyl)amino]ethanol
|
|
CN103086956A
|
|
Purification method of clevidipine butyrate intermediate
|
|
CN103073485A
|
|
Preparation method for clevidipine butyrate
|
|
CN103864796A
|
|
Purification production method of pilsicainide hydrochloride
|
